- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
How We Fall into Clinical Trial Metrics Malpractice
Effective clinical trial management depends on accurate and unbiased performance measurement.
Effective clinical trial management depends on accurate and unbiased performance measurement. Performance measures are the lens through which managers monitor clinical trials and assess trial quality. Using the wrong metric or having biased measures distorts managers’ view and hinders effective trial oversight. It is important, then, that clinical trials managers make sure that they are using the right performance measures.
In this Applied Clinical Trials blog, Dr Michael J. Howley outlines four common types of malpractice in clinical trial performance measurement. Read more here.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
